Abstract

Novel Approaches to Topical Psoriasis Therapy

Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin

Issue: Sep/Oct 2015 - Volume 19, Number 5

Page(s): 357-365

Download in electronic PDF format for $75
  • Novel Approaches to Topical Psoriasis Therapy Page 1
  • Novel Approaches to Topical Psoriasis Therapy Page 2
  • Novel Approaches to Topical Psoriasis Therapy Page 3
  • Novel Approaches to Topical Psoriasis Therapy Page 4
  • Novel Approaches to Topical Psoriasis Therapy Page 5
  • Novel Approaches to Topical Psoriasis Therapy Page 6
  • Novel Approaches to Topical Psoriasis Therapy Page 7
  • Novel Approaches to Topical Psoriasis Therapy Page 8
  • Novel Approaches to Topical Psoriasis Therapy Page 9

Abstract

Topical corticosteroids are the cornerstone of treatment for the majority of psoriasis patients. However, potential side effects of topical corticosteroids (i.e., cutaneous atrophy, telangiectasias, hypothalamic-pituitary axis suppression), coupled with the complex pathophysiology of psoriasis and the individual needs/preferences of psoriasis patients, represent a few of the limitations associated with topical corticosteroid monotherapy. While the combination of some agents with varying mechanisms of action has proven to be an effective strategy for improving efficacy and reducing concomitant drug application, others have displayed less efficacy, harm, and/or reduced cost-effectiveness. The purpose of this article is to review novel topical therapeutic combinations for the management of psoriasis and explore the role compounding pharmacies can have in providing healthcare providers and patients with effective and affordable alternative psoriasis therapies.

Related Keywords

  • plaque psoriasis
  • immune-modulated keratinocyte hyperproliferation
  • skin disorders
  • topical preparations
  • drug combination therapy
  • topical corticosteroids
  • anti-inflammatory therapy
  • inflammation
  • adverse effects
  • topical vitamin D3 analogues
  • calcipotriene
  • calcipotriol
  • topical retinoids
  • retinoic acids
  • tazarotene
  • topical calcineurin inhibitors
  • tacrolimus
  • topical salicylic acid
  • keratolytic
  • topical anthralin
  • skin irritation
  • topical urea
  • drug safety
  • topical methotrexate
  • folic acid antagonist
  • individualized therapy
  • patient adherence
  • drug costs

Related Categories

  • DERMATOLOGY
  • STABILITIES, COMPATIBILITIES
  • ADVERSE DRUG EVENTS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • PATIENT COMPLIANCE
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
May/Jun 2017
Pg. 205-211
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
May/Jun 2011
Pg. 204-213
Treatment Options for Psoriasis
Author(s): Williams LaVonn A, Humphreys Erica
Jul/Aug 2022
Pg. 329
Psoriasis Topical Ointment
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 101-105
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs
Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
Jan/Feb 2023
Pg. 57
Psoriasis Topical Ointment
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 94-96
Low-dose Naltrexone Therapy for Psoriasis
Author(s): Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Jul/Aug 2020
Pg. 337-345
Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis
Author(s): Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S
Sep/Oct 2004
Pg. 345-352
Head to Toe Solutions: A Quick Review of Current Therapies
Author(s): Paoletti James E
Jan/Feb 2013
Pg. 74-85
View Sample
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Mar/Apr 1997
Pg. 121-122
The Compatibility of Common Respiratory Therapy Drug Combinations
Author(s): Owsley Heather D, Rusho William F
Nov/Dec 2014
Pg. 512-515
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Author(s): Heustess Allie, Asbill Scott, Eagerton David, Arnold John
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Sep/Oct 2012
Pg. 386-393
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Author(s): Zur Eyal
Jan/Feb 2008
Pg. 64
Cyclosporine Topical Gel
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Mar/Apr 2021
Pg. 146-155
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Jul/Aug 2024
Pg. 271-277
Combination Therapy of Oral LDN and Topical Pentoxifylline, Rifampin, Clindamycin for Hidradenitis Suppurativa
Author(s): Bertrand Joe, Bruno Matthew, Komuves Andrew, Jones Nat, Carper Kameryn, Banov Fabiana, Carvalho Maria